申请人:Aventis Pharma S.A.
公开号:EP1298125A1
公开(公告)日:2003-04-02
New benzimidazole compounds of formula (I) and their use as cyclin-dependent kinases inhibitors compounds as well as new pharmaceutical compositions containing them.
新的苯并咪唑化合物的化学式(I),以及它们作为细胞周期依赖性激酶抑制剂化合物的用途,以及含有它们的新的药物组合物。